Decline depth
-32.4%
From rolling 252-day high of $37.77, 99d ago.
Past the 30% Amber threshold.
Red ListRecovering
TCMDTactile Systems Technology, Inc
Healthcare · Medical Devices · small-cap ($547M)
-32.4%
from rolling 252-day high of $37.77 set 2026-02-18 · 99d ago
Current
$25.55
Decline depth
-32.4%
Decline σ
3.4σ
TFC
1/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$TCMD landed on the list 2026-03-18, down 28.4% from its 52-week high that day — now down -32.4%.
That's 2.8 percentage points deeper than the day it joined. It bottomed 40.6% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-18 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
TCMD qualifies for the Red List on decline depth.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
3.4σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.19% per day).
The structural read
What price action says about TCMD.
TCMD qualifies for the Red List on decline depth — down -32.4% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown. Depth plus recency: this is the pattern many investors call a falling knife.
Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.
Broken Stocks stops here — it flags the structure, it doesn't build the upside case. Working out whether TCMD's turn is investable is what our sister tool does: ConvictionEdge — triple-engine conviction research on names showing a recovery signal.
Upstream TFC read: strong alignment, current phase monthly. Last bar types — daily 2U (green), weekly 1 (green), monthly 3 (green).
Earnings on file: 2026-05-04. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $9.34
57.0% of range
52W high $37.77
Sector context · Healthcare
194 other Healthcare tickers are on Broken Stocks.
88
Red List
47
Amber
59
Watch
-36.0%
Median decline
Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →
Related — same sector
Closest decliners to TCMD
Amber ListRecovering
ARQT
Arcutis Biotherapeutics, Inc.
Amber List
COO
The Cooper Companies, Inc.
Red List
INBX
Inhibrx Biosciences, Inc.
Red ListRecovering
VNDA
Vanda Pharmaceuticals Inc.
Amber ListRecovering
STVN
Stevanato Group S.p.A.
Amber List
ALHC
Alignment Healthcare, Inc.
Questions about TCMD
What people ask.
Why is TCMD on Broken Stocks?
TCMD qualifies for the Red List on decline depth. It is down -32.4% from its rolling 252-day high of $37.77, set on 2026-02-18 — 99d ago. It additionally carries a Recovering badge — see below.
What does the Recovering badge mean for TCMD?
Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — TCMD is still Red List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.
Is TCMD a falling knife?
By the most common technical definition — a steep, recent breakdown from a fresh high — yes. TCMD is down -32.4% from its 52-week high of $37.77, set 99d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.
Is TCMD a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is TCMD trading inside its 52-week range?
At $25.55, TCMD sits 57.0% of the way from its 52-week low ($9.34) to its 52-week high ($37.77). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has TCMD been declining?
The current 32.4% decline accrued over 99d, which annualizes to roughly -119.5% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does TCMD compare to its sector?
There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 107 showing recovering structural signals. Median sector decline is -36.0% — TCMD's decline is shallower than the sector median.
Does TCMD's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-04) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.